Related content

Camptocormia and Parkinson's disease: MR imaging

By Bonneville Fabrice  

European Radiology, Vol. 18, Iss. 8, 2008-08 ,pp. : 1710-1719

Springer Publishing Company

Access to resources Recommend Favorite

Imaging of dopamine transporters and D₂ receptors in patients with Parkinson’s disease and multiple system atrophy

By Knudsen G.   Karlsborg M.   Thomsen G.   Krabbe K.   Regeur L.   Nygaard T.   Videbæk C.   Werdelin L.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 12, 2004-12 ,pp. : 1631-1638

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease

By Lokkegaard A.   Werdelin L.   Regeur L.   Karlsborg M.   Jensen S.   Brødsgaard E.   Madsen F.   Lonsdale M.   Friberg L.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 508-516

Springer Publishing Company

Access to resources Recommend Favorite

Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson’s Disease

By Neal Krista   Shakerdge Naomi   Hou Steven   Klunk William   Mathis Chester   Nesterov Evgueni   Swager Timothy   McLean Pamela   Bacskai Brian  

Molecular Imaging and Biology, Vol. 15, Iss. 5, 2013-10 ,pp. : 585-595

Springer Publishing Company

Access to resources Recommend Favorite

Usefulness of brain ^99mTc-TRODAT-1 SPET for the evaluation of Parkinson’s disease

By Huang Wen-Sheng   Lee Meei-Shyuan   Lin Jiann-Chyun   Chen Cheng-Yu   Yang Yu-Wen   Lin Shinn-Zong   Wey Shiaw-Pyng  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 2, 2004-02 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite